P1240: ANTI-PD-1-ANTIBODY (TISLELIZUMAB) COMBINED WITH DEACETYLASE INHIBITOR (CHIDAMIDE), LENALIDOMIDE AND ETOPOSIDE FOR THE TREATMENT OF REFRACTORY/RELAPSED EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA, NASAL

ABSTRACT:

SUBMITTER: Zhang L 

PROVIDER: S-EPMC9431228 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature